7-Diethylamino-3(2`-benzoxazolyl)-coumarin is a novel microtubule inhibitor with antimitotic activity in multidrug resistant cancer cells.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Su-Nam | - |
dc.contributor.author | Kim, Nam Hyun | - |
dc.contributor.author | Park, Yeon Sook | - |
dc.contributor.author | Kim, Hanna | - |
dc.contributor.author | Lee, Seokjoon | - |
dc.contributor.author | Wang, Qian | - |
dc.contributor.author | Kim, Yong Kee | - |
dc.date.accessioned | 2022-04-19T10:47:33Z | - |
dc.date.available | 2022-04-19T10:47:33Z | - |
dc.date.issued | 2009-06 | - |
dc.identifier.issn | 0006-2952 | - |
dc.identifier.issn | 1873-2968 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/148057 | - |
dc.description.abstract | Microtubules are a proven target for anticancer drug development because they are critical for mitotic spindle formation and the separation of chromosomes at mitosis. We here report a novel synthetic microtubule inhibitor 7-diethylamino-3(2′-benzoxazolyl)-coumarin (DBC). DBC causes destabilization of microtubules, leading to a cell cycle arrest at G2/M stage. In addition, human cancer cells are more sensitive to DBC (IC50 44.8–475.2 nM) than human normal fibroblast (IC50 7.9 μM), and DBC induces apoptotic cell death of cancer cells. Furthermore, our data show that DBC is a poor substrate of drug efflux pumps and effective against multidrug resistant (MDR) cancer cells. Taken together, these results describe a novel pharmacological property of DBC as a microtubule inhibitor, which may make it an attractive new agent for treatment of MDR cancer. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.title | 7-Diethylamino-3(2`-benzoxazolyl)-coumarin is a novel microtubule inhibitor with antimitotic activity in multidrug resistant cancer cells. | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1016/j.bcp.2009.03.007 | - |
dc.identifier.scopusid | 2-s2.0-67349212426 | - |
dc.identifier.wosid | 000266084600003 | - |
dc.identifier.bibliographicCitation | BIOCHEMICAL PHARMACOLOGY, v.77, no.12, pp 1773 - 1779 | - |
dc.citation.title | BIOCHEMICAL PHARMACOLOGY | - |
dc.citation.volume | 77 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 1773 | - |
dc.citation.endPage | 1779 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0006295209001828?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.